Denkapparat Operations Gmb H Acadia Pharmaceuticals Inc Transaction History
Denkapparat Operations Gmb H
- $67.7 Billion
- Q4 2024
A detailed history of Denkapparat Operations Gmb H transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Denkapparat Operations Gmb H holds 10,626 shares of ACAD stock, worth $196,474. This represents 0.29% of its overall portfolio holdings.
Number of Shares
10,626Holding current value
$196,474% of portfolio
0.29%Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
298Shares Held
160MCall Options Held
901KPut Options Held
314K-
Baker Bros. Advisors LP New York, NY42.9MShares$793 Million7.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$258 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$253 Million3.36% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$223 Million0.0% of portfolio
-
State Street Corp Boston, MA5.97MShares$110 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.99B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...